| |
|
|
|
Rigel Pharmaceuticals Inc.  
|
|
3.76 -0.05 (-0.01%) |
01-15 16:00 |
|
Open: |
3.8 |
Pre close: |
3.81 |
Target:
|
4.71 
|
|
High: |
4.035 |
Low: |
3.7 |
Resistance:
|
4.03
4.71
|
|
Volume: |
4,609,840 |
Market Cap: |
635M |
Support:
|
3.46
3.10
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.66
|
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
3.62 |
Signal(12,26,9): |
0.13  |
|
MA(100): |
2.83 |
Stochastic Oscillator |
%K(14,3):
|
80.31 |
|
MA(250): |
2.37 |
%D(3): |
67.87 |
|
Average Volume(K) |
3-Month: |
251227
|
52-Week |
High:
|
5.24 |
|
10-Days: |
252336 |
Low: |
1.23 |
|
RSI |
RSI(14):
|
62.34 |
Change(%): |
25.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.165 |
Return on Equity (ttm) |
-46.2 |
Shares Out. (M) |
168.98 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-12.3 |
Shares Float (M) |
168.46 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.31 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
-11.8 |
% Held by Institutions |
85.25 |
|
Forward EPS |
-0.400 |
Gross Profit (p.s.) |
0.033 |
Shares Short (K) |
22600 |
|
Book Value (p.s.) |
0.300 |
EBITDA (p.s.) |
-0.159 |
P/E |
-22.79 |
|
Sales Per Share |
0.625 |
Qtrly Earnings Growth |
0.00 |
P/BV |
12.53 |
|
Profit Margin |
-26.25 |
Operating Cash Flow
(M) |
-46.26 |
P/S |
6.02 |
|
Operating Margin |
-26.03 |
Levered Free Cash Flow
(M) |
-17.98 |
P/CF |
-13.73 |
|
|
|
|
|
|
